MACQUARIE GROUP LTD - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 194 filers reported holding HERON THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
MACQUARIE GROUP LTD ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$31,000
+47.6%
6,996
-5.8%
0.00%
Q2 2022$21,000
-50.0%
7,4230.0%0.00%
Q1 2022$42,000
-38.2%
7,4230.0%0.00%
Q4 2021$68,000
-32.0%
7,423
-20.4%
0.00%
Q3 2021$100,000
+61.3%
9,321
+131.6%
0.00%
Q2 2021$62,000
-4.6%
4,0250.0%0.00%
Q1 2021$65,000
-40.4%
4,025
-21.5%
0.00%
Q4 2020$109,000
+43.4%
5,1270.0%0.00%
Q3 2020$76,000
+18.8%
5,127
+18.5%
0.00%
Q2 2020$64,0004,3270.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
TANG KEVIN C 760$1,900100.00%
Velan Capital Investment Management LP 2,500,000$6,250,0005.52%
GREAT POINT PARTNERS LLC 6,360,161$15,900,4033.12%
Cheyne Capital Management (UK) LLP 318,008$795,0201.39%
TANG CAPITAL MANAGEMENT LLC 3,755,934$9,389,8351.36%
Rubric Capital Management LP 11,750,000$29,375,0001.28%
Orchard Capital Management, LLC 1,391,080$3,477,7001.17%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 267,028$667,5700.81%
CM Management, LLC 250,000$6250.75%
Tejara Capital Ltd 493,619$1,234,0480.71%
View complete list of HERON THERAPEUTICS INC shareholders